VR
Veraxa Biotech Holding AG
VRXA · NASDAQ
$1.48 -1.66% (-$0.03)
1M -17.98%
Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Stability
15 /100
Unstable Beta 0.26x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VRXA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christoph Antz
Employees
8
Headquarters
Heidelberg